Los Angeles Capital Management
VRCA icon

Los Angeles Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Los Angeles Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,534
Closed -$389K – 1535
2020
Q2 		$389K Buy
3,534
+2,007
+131% +$232K ﹤0.01% 1209
2020
Q1 		$167K Buy
+1,527
New +$201K ﹤0.01% 1221

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Los Angeles Capital Management's VRCA Position: Q3 2020 in Review

Los Angeles Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q3 2020, closing a stake of 3,534 shares — an estimated $389K sold.

Los Angeles Capital Management first reported a position in VRCA in Q1 2020 and held it in 2 quarters. The position peaked at $389K in Q2 2020. 47 funds tracked by Wall St. Rank hold VRCA as of Q3 2020.

  • Los Angeles Capital Management reported no remaining Verrica Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Los Angeles Capital Management sold 3,534 Verrica Pharmaceuticals shares in Q3 2020, an estimated $389K.
  • Los Angeles Capital Management first reported a position in Verrica Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • Los Angeles Capital Management's Verrica Pharmaceuticals position peaked at $389K in Q2 2020.
  • 47 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2020.

Based on Los Angeles Capital Management's 13F filing for Q3 2020, filed 2 Nov 2020.